148 related articles for article (PubMed ID: 35584320)
1. Lessons From a Systematic Literature Search on Diagnostic DNA Methylation Biomarkers for Colorectal Cancer: How to Increase Research Value and Decrease Research Waste?
Feng Z; Oberije CJG; van de Wetering AJP; Koch A; Wouters KAD; Vaes N; Masclee AAM; Carvalho B; Meijer GA; Zeegers MP; Herman JG; Melotte V; van Engeland M; Smits KM
Clin Transl Gastroenterol; 2022 Jun; 13(6):e00499. PubMed ID: 35584320
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
[TBL] [Abstract][Full Text] [Related]
4. Using Comorbidity Pattern Analysis to Detect Reliable Methylated Genes in Colorectal Cancer Verified by Stool DNA Test.
Cheng YC; Wu PH; Chen YJ; Yang CH; Huang JL; Chou YC; Chang PK; Wen CC; Jao SW; Huang HH; Tsai YH; Pai TW
Genes (Basel); 2021 Sep; 12(10):. PubMed ID: 34680934
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive DNA methylation biomarkers in colorectal cancer: A systematic review.
Xue M; Lai SC; Xu ZP; Wang LJ
J Dig Dis; 2015 Dec; 16(12):699-712. PubMed ID: 26565661
[TBL] [Abstract][Full Text] [Related]
6. Colorectal cancer screening using a stool DNA-based SDC2 methylation test: a multicenter, prospective trial.
Kim CW; Kim H; Kim HR; Kye BH; Kim HJ; Min BS; Oh TJ; An S; Lee SH
BMC Gastroenterol; 2021 Apr; 21(1):173. PubMed ID: 33858326
[TBL] [Abstract][Full Text] [Related]
7. Prognostic DNA methylation markers for sporadic colorectal cancer: a systematic review.
Draht MXG; Goudkade D; Koch A; Grabsch HI; Weijenberg MP; van Engeland M; Melotte V; Smits KM
Clin Epigenetics; 2018; 10():35. PubMed ID: 29564023
[TBL] [Abstract][Full Text] [Related]
8. Fecal DNA methylation markers for detecting stages of colorectal cancer and its precursors: a systematic review.
Raut JR; Guan Z; Schrotz-King P; Brenner H
Clin Epigenetics; 2020 Aug; 12(1):122. PubMed ID: 32778176
[TBL] [Abstract][Full Text] [Related]
9. Screening for colon cancer: A test for occult blood.
Khakimov N; Khasanova G; Ershova K; Gibadullina L; Vetkina T; Lobisheva G; Chumakova A
Int J Risk Saf Med; 2015; 27 Suppl 1():S110-1. PubMed ID: 26639687
[TBL] [Abstract][Full Text] [Related]
10. Identification of DNA methylation markers for early detection of CRC indicates a role for nervous system-related genes in CRC.
Rademakers G; Massen M; Koch A; Draht MX; Buekers N; Wouters KAD; Vaes N; De Meyer T; Carvalho B; Meijer GA; Herman JG; Smits KM; van Engeland M; Melotte V
Clin Epigenetics; 2021 Apr; 13(1):80. PubMed ID: 33858496
[TBL] [Abstract][Full Text] [Related]
11. Novel DNA methylation biomarkers show high sensitivity and specificity for blood-based detection of colorectal cancer-a clinical biomarker discovery and validation study.
Jensen SØ; Øgaard N; Ørntoft MW; Rasmussen MH; Bramsen JB; Kristensen H; Mouritzen P; Madsen MR; Madsen AH; Sunesen KG; Iversen LH; Laurberg S; Christensen IJ; Nielsen HJ; Andersen CL
Clin Epigenetics; 2019 Nov; 11(1):158. PubMed ID: 31727158
[TBL] [Abstract][Full Text] [Related]
12. Cancer diagnostic tools to aid decision-making in primary care: mixed-methods systematic reviews and cost-effectiveness analysis.
Medina-Lara A; Grigore B; Lewis R; Peters J; Price S; Landa P; Robinson S; Neal R; Hamilton W; Spencer AE
Health Technol Assess; 2020 Nov; 24(66):1-332. PubMed ID: 33252328
[TBL] [Abstract][Full Text] [Related]
13. A systematic review and quantitative assessment of methylation biomarkers in fecal DNA and colorectal cancer and its precursor, colorectal adenoma.
Liu R; Su X; Long Y; Zhou D; Zhang X; Ye Z; Ma J; Tang T; Wang F; He C
Mutat Res Rev Mutat Res; 2019; 779():45-57. PubMed ID: 31097151
[TBL] [Abstract][Full Text] [Related]
14. Aberrant methylation of NPY, PENK, and WIF1 as a promising marker for blood-based diagnosis of colorectal cancer.
Roperch JP; Incitti R; Forbin S; Bard F; Mansour H; Mesli F; Baumgaertner I; Brunetti F; Sobhani I
BMC Cancer; 2013 Dec; 13():566. PubMed ID: 24289328
[TBL] [Abstract][Full Text] [Related]
15. Epigenome-wide discovery and evaluation of leukocyte DNA methylation markers for the detection of colorectal cancer in a screening setting.
Heiss JA; Brenner H
Clin Epigenetics; 2017; 9():24. PubMed ID: 28270869
[TBL] [Abstract][Full Text] [Related]
16. Review of Blood-Based Colorectal Cancer Screening: How Far Are Circulating Cell-Free DNA Methylation Markers From Clinical Implementation?
Worm Ørntoft MB
Clin Colorectal Cancer; 2018 Jun; 17(2):e415-e433. PubMed ID: 29678513
[TBL] [Abstract][Full Text] [Related]
17. Technical considerations in PCR-based assay design for diagnostic DNA methylation cancer biomarkers.
Massen M; Lommen K; Wouters KAD; Vandersmissen J; van Criekinge W; Herman JG; Melotte V; Schouten LJ; van Engeland M; Smits KM
Clin Epigenetics; 2022 Apr; 14(1):56. PubMed ID: 35477541
[TBL] [Abstract][Full Text] [Related]
18. Fecal Occult Blood Tests in Colorectal Cancer Screening: Systematic Review and Meta-analysis of Traditional and New-generation Fecal Immunochemical Tests.
Meklin J; SyrjÄnen K; Eskelinen M
Anticancer Res; 2020 Jul; 40(7):3591-3604. PubMed ID: 32620599
[TBL] [Abstract][Full Text] [Related]
19. Options for screening for colorectal cancer.
Atkin W
Scand J Gastroenterol Suppl; 2003; (237):13-6. PubMed ID: 12797674
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]